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We recently reported a two-stage genomewide screen of 48 sib pairs affected with intracranial aneurysms (IAs) that
revealed suggestive linkage to chromosome 19q13, with a LOD score of 2.58. The region supporting linkage
spanned ∼22 cM. Here, we report a follow-up study of the locus at 19q13, with a sample size expanded to 139
affected sib pairs, along with 83 other affected relative pairs (222 affected relative pairs in total). Suggestive linkage
was observed in both independent sample sets, and linkage was signiﬁcant in the combined set at 70 cM (LOD
score 3.50; ) and at 80 cM (LOD score 3.93; ). Linkage was highly signiﬁcant at 70 cMPp .00006 Pp .00002
(LOD score 5.70; ) and at 80 cM (LOD score 3.99; ) when a covariate measuring thePp .000001 Pp .00005
number of affected individuals in the nuclear family was included. To evaluate further the contribution to the
linkage signal from families with more than two affected relatives, we performed model-based linkage analysis with
a recessive model and a range of penetrances, and we obtained maximum linkage at 70 cM (LOD score 3.16;
) with a penetrance of 0.3. We then estimated location by using GENEFINDER. The most likely locationPp .00007
for a gene predisposing to IAs in the Finnish population is in a region with a 95% conﬁdence interval of 11.6 cM
( ) centered 2.0 cM proximal to D19S246.Pp .00007
Intracranial berry aneurysms (IAs [MIM 105800]) are
saccular outpouchings of the intracranial arteries, most
commonly at arterial bifurcations, characterized by ar-
terial wall remodeling. Cerebral arteries are especially vul-
nerable to aneurysm formation, since they lack an exter-
nal elastic lamina. Most cases of ruptured IAs result in a
subarachnoid hemorrhage, associated with high morbid-
ity and mortality. We showed previously that ∼10% of
individuals with IA in the Finnish population have a fami-
ly history of IA, and we estimated the sibling relative risk
to be 9%–16% (Ronkainen et al. 1993, 1997). Our goal
has been to recruit multiplex families with IA from the
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Finnish population (Wills et al. 2003) so that candidate
regions for susceptibility genes could be investigated by
use of linkage analysis. We recently reported the results
(Olson et al. 2002c) of a genomewide scan that used a
10-cM intermarker interval (Phase I, stage 1) with an
initial set of 48 affected sib pairs (ASPs). Additionalmark-
ers in regions with LOD score 10.8 ( ) were ge-a ≈ 0.05
notyped to either support or reject the linkage (Phase I,
stage 2) (Olson et al. 2002c). A two-phase, two-stage
study design was adopted to reduce the labor and cost of
performing the genomewide scan (Guo and Elston 2001).
The most promising signal was on chromosome 19q,
which reached a maximum multipoint LOD score of 2.58
between markers D19S245 and D19S246, a region sup-
ported by a maximum LOD 1 of ∼22 cM.
Here, we report a follow-up study (Phase II) of the
19q region with an expanded sample size and increased
markermap–density. To date, we have collected 346Finn-
ish families with at least two affected individuals among
ﬁrst- and second-degree relatives (Wills et al. 2003). An
individual was scored as “affected with IA” when at least
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Table 1
Number of Affected Pairs per Family in IA Data Sets
NO. OF AFFECTED NO. OF FAMILIES IN DATA SET
NO. OF
PAIRS,
COMBINEDaSib Pairs Half-Sib Pairs Otherb Phase I Phase II Combined
1 29 29 29
2 1 1 2
3 3 3 9
1 1 1 1
1 10 48 58 58
1 1 1 4 5 10
1 2 3 3 6 18
1 4 1 1 5
1 2 2 2 6
1 5 1 1 6
2 8 1 1 10
3 3 3 6 18
3 3 1 1 6
4 1 1 4
6 1 2 3 18
10 1 1 10
11 1 1 1 12
Total 22 99 121 222
a The number of affected pairs computed as the sum of all pair types multiplied by
the number of families.
b Includes non-sib andnon-half-sib pairs, such as avuncular (aunt/uncle toniece/nephew),
grandparental, and cousin pairs.
one saccular aneurysm was treated surgically, was iden-
tiﬁed at autopsy, or—in two instances where surgical
treatment was contraindicated—when an IA was iden-
tiﬁed only by magnetic resonance angiography (MRA).
Families with nonsaccular aneurysms or predisposing
conditions—such as polycystic kidney disease, Ehlers-
Danlos syndrome, and Marfan syndrome (Ronkainen et
al. 1997; Schievink 1997)—were excluded. There were
121 extended families who had two or more living rela-
tives affected with IA—and who were therefore suitable
for genetic studies—who consented to donate blood.
These families had a total of 362 subjects with IA (both
living and dead), of whom 272 had spontaneous ruptures,
with 63 of the ruptures causing death, and 90 subjects
had IAs detected by imaging. All but two of the subjects
with IA detected by imaging had their IAs repaired sur-
gically. From these families, we selected individuals with
at least one ASP per family. For such families, we also
genotyped available parents, additional siblings, and ad-
ditional family members, if additional affected relatives
were available.
Table 1 summarizes the families and numbers of ge-
notyped affected-relative pairs (ARPs) included in Phase
I and in Phase II of this study. The Phase I sample set
consisted of 22 extended Finnish families comprising 24
sibships and 48 ASPs; here, an additional 16 ARPs were
included from those families (for two of the extended
families, samples from key connecting individuals were
unavailable) (Olson et al. 2002c). The Phase II sample
set consisted of 99 Finnish families comprising 65 sib-
ships and 91 ASPs plus 67 other ARPs; a combined
sample (Phase I plus Phase II) consisted of 139 ASPs and
an additional 83 ARPs (222 ARPs in total). Phase I in-
cluded samples from asymptomatic ﬁrst-degree relatives
screened for IA by MRA (Ronkainen et al. 1997); con-
sequently, there was proportionally approximately dou-
ble the number of IAs detected by imaging in Phase I
compared with Phase II.
There were 35, 11, and 28 cases of IA characterized
by rupture and survival, rupture causing death, and de-
tection by imaging, respectively, in Phase I, comparedwith
174, 52, and 62 in Phase II ( with the PearsonP ! .015
x2 test). Inclusion in ARP methods of cases of asymptom-
atic IA detected by imaging is expected to improve the
power to detect linkage to predisposition to IA, although
it will result in erroneously calling individuals affected if
the phenotype studied is ruptured IA. Phase I probands
were all recruited through the University Hospital of Kuo-
pio in eastern Finland, whereas Phase II probands were
recruited through either theUniversityHospital ofKuopio
or the UniversityHospital ofHelsinki in southernFinland.
Eastern Finland is a younger population that underwent
a rapid expansion from a small number of founders,
whereas coastal southern Finland has been stably popu-
lated for millennia (Norio 2003; Varilo et al. 2003). Fami-
lies from both sites were ascertained from registries of
patients who underwent surgical treatment for IA; the
proportion of cases of IA detected by imaging was the
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Table 2
Results of Standard and Covariate Linkage Analyses for IA Data Sets
LOCATION (CM)
AND MODEL
PHASE I
(48 ASPs, 64 ARPs)
PHASE II
(91 ASPs, 158 ARPs)
COMBINED
(139 ASPs, 222 ARPs)
LOD Pa bb gc LOD Pa bb gc LOD Pa bb gc
60:d
Baseline (2-parameter) 2.95 .0002 .00 1.14 .34 .145 .00 .32 2.37 .0008 .00 .64
Baseline (1-parameter) 2.25 .0006 .47 .17 .188 .07 1.62 .0032 .20
Sex 2.41 .0024 .49 .24 1.02 .063 .10 .22 1.91 .0077 .21 .13
Naff 3.13 .0004 .69 .64 .34 .334 .04 .06 2.39 .0025 .15 .16
70:e
Baseline (2-parameter) 2.43 .0007 .00 1.12 1.35 .0102 .00 .63 3.50 .00006 .00 .80
Baseline (1-parameter) 1.22 .0089 .30 1.06 .0136 .21 2.26 .0006 .25
Sex 1.26 .0355 .29 .08 1.45 .0226 .22 .18 2.38 .0026 .25 .08
Naff 2.55 .0017 .47 .51 3.21 .0004 .16 .42 5.70 .000001 .23 .43
80:f
Baseline (2-parameter) 3.07 .0002 .00 1.31 1.40 .0090 .00 .63 3.93 .00002 .00 .85
Baseline (1-parameter) 1.82 .0019 .43 .88 .022 .18 2.48 .00036 .26
Sex 1.86 .0086 .45 .11 1.12 .0495 .17 .14 2.63 .0014 .26 .11
Naff 2.03 .0058 .47 .21 2.03 .0058 .08 .23 3.99 .00005 .20 .24
NOTE.—Signiﬁcant ( ) covariate effects are underlined.P ! .05
a P value for entire model (overall linkage).
b Parameter estimate b, average linkage in the sample.
c Parameter estimate g, change in linkage as a function of the covariate.
d Between markers D19S587 and D19S876.
e Between markers D19S178 and D19S545.
f Between markers D19S246 and D19S601.
only detectable phenotypic difference between the sub-
populations. Nonetheless, there may have been additional
undetected heterogeneity due to the population structure.
Informed consent was obtained from all the research par-
ticipants; the studywas approved by the ethics committees
at the Universities of Kuopio and Helsinki, as well as by
the institutional review board of the Wayne State Uni-
versity School of Medicine.
Research participants were genotyped for 18 micro-
satellite markers spanning a 52-cM region on chromo-
some 19 that included the previous linkage signal. Mi-
crosatellite markers from a map generated byMarshﬁeld
Genetics (Center for Medical Genetics) were selected in
order to obtain an ∼3-cM map distribution and an av-
erage 80% heterozygosity, on the basis of family data
from CEPH. Genomic DNA was isolated from blood by
use of a DNA isolation kit (Puregene [Gentra Systems]).
Template DNA and positive and negative controls were
generated by linear whole-genome ampliﬁcationwith the
primer-extension preampliﬁcation protocol (Zhang et al.
1992; Kuivaniemi et al. 2002). Primers for the micro-
satellites were ordered from Research Genetics, and ge-
notyping was performed as described elsewhere (Olson
et al. 2002c). Alleles were assigned on the basis of size
in comparison with CEPH controls (1331-1 and 1331-2)
and were stored in a custom Oracle database. Micro-
satellite markers were ordered according to version 10
of the Marshﬁeld genetic map (Center for Medical Ge-
netics). Markers genetically at the same locus were or-
dered according to the National Center for Biotechnol-
ogy Information (NCBI) build 29 physical map. Family
relationships within each pedigree, for families with ge-
nome scan data—that is, the Phase I samples—were
tested using a genomewide test for genetic relationships
(Olson 1999b). One non-sib pair was detected in one of
the sibships in a family (family 21) and was removed
from ASP analysis (Olson et al. 2002c) but was included
as a half-sib pair in ARP analyses. Data were checked
for possible genotyping errors, for all families, by use of
the program MARKERINFO (S.A.G.E. 2003). The lab-
oratory genotyping error rate was ∼1%. No families were
excluded. Multipoint identity-by-descent (IBD) estimates
were obtained for all ARPs through use of the program
GENIBD (S.A.G.E. 2003).
Our linkage design tests allele sharing by robust,
model-free ARP analysis (Olson et al. 2002a, 2002b) to
address the complex nature of IA (Olson et al. 2002c).
For ease of comparison of these results with our pre-
viously published data, baseline LOD scores were com-
puted, both by a model-free, two-parameter linkage
method (Risch 1990) and by a one-parameter modiﬁca-
tion that allows for the inclusion of covariates as a sur-
rogate measure of linkage heterogeneity. Speciﬁcally, we
ﬁtted the one-parameter modiﬁcation (Goddard et al.
2001) of the conditional-logistic parameterization of the
ASP LOD score method introduced by Olson (1999a).
This method allows for the inclusion of continuous, as
well as dichotomous, covariates that were incorporated
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Table 3
The Covariate Sex for Affected Subjects
in the Phase I and Phase II Samples
SEX
NO. (%) OF
AFFECTED SUBJECTS
Phase I Phase II Total
Males 32 (43) 122 (46) 154 (45)
Females 42 (57) 146 (54) 188 (55)
Total 74 268 342
Table 4
The Covariate “Number of Affected First-
Degree Relatives” for the Phase I and Phase II
Samples
NO. OF
FIRST-DEGREE
AFFECTED
RELATIVES
NO. (%) OF FAMILIES
Phase I Phase II Total
0 0 27 (27) 27 (22)
2 10 (42) 46 (47) 56 (46)
3 12 (50) 20 (20) 32 (26)
4 1 (4) 2 (2) 3 (3)
5 1 (4) 1 (1) 2 (2)
6 0 0 0
7 0 1 (1) 1 (1)
Total 24 97 121
into the analysis by setting .Kl (x)p exp (b g x )1 k kkp1
Parameterization is in terms of offspring recurrence risk
ratio (l1), conditional on K covariates xk. “Average”
linkage in the sample is measured by the parameter b;
the change in linkage as a function of the covariates is
measured by gk. All covariates were centered on their
sample mean before inclusion in the linkage model, to
simplify speciﬁcation of constraints on parameter esti-
mates, improve numerical stability, and so that b reﬂects
average allele sharing. In general, values of b and gk
depend on the choice of coding scheme of the covariates;
here, a linear transformation of the covariate does not
change either the LOD score or the estimates of covari-
ate-speciﬁc recurrence risk ratios. What is more impor-
tant is that conclusions about the existence of locus het-
erogeneity and the extent or nature of locus hetero-
geneity do not depend on the estimated value of b (which
may equal 0). To reduce the number of additional pa-
rameters needed for each covariate from two to one
(Goddard et al. 2001), the MZ twin relative risk l2(x)
was constrained as . Thel (x)p 3.634l (x ) 2.6342 1 k
restriction is a reparameterization of theWhittemore and
Tu (1998) minmax constraint. The minmax one-param-
eter ASP LOD score was shown by Whittemore and Tu
(1998) to be more robust against misspeciﬁcations than
other one-parameter models, and it performed as well
as or better than the constrained likelihood test that is
based on the two-parameter model by Risch (1990). The
one-parameter modiﬁcation of the conditional-logistic
parameterization model is implemented in the program
LODPAL (S.A.G.E. 2003). P values were obtained by
asymptotic distributions of likelihood ratio tests (God-
dard et al. 2001). LOD scores (Nyholt 2000) are re-
ported as the likelihood ratio statistics divided by 4.605
(i.e., 2loge10); critical values were obtained as described
by Self and Liang (1987), to allow testing of both the
signiﬁcance of the contribution of a covariate and the
overall evidence for linkage. The computer program
GENEFINDER (Liang et al. 2001; Chiu et al. 2002;
Glidden et al. 2003; Department of Biostatistics Web site,
Johns Hopkins University) was used to obtain 95% CIs
for the location of the gene on chromosome 19. Multi-
point model-based linkage analysis was performed using
MLOD (S.A.G.E. 2003).
Results of the model-free linkage analyses are sum-
marized in table 2. Through use of the two-parameter
model, increased IBD sharingwas reﬂected by LODscores
of 3.07 ( ), 1.40 ( ), and 3.93 (Pp .0002 Pp .0090 Pp
) in the Phase I, Phase II, and combined samples,.00002
respectively, at 80 cM. The one-parameter model gave
lower LOD scores, indicating that themode of inheritance
in our sample was substantially different from the min-
max model, which assumes a genetic mode of inheritance
approximately halfway between dominant and recessive.
Model parameters in the two-parameter case suggest a
recessive model of inheritance. However, since estimation
of the mode of inheritance for a complex disease lacks
precision, and because the two-parameter model is not
suitable for covariate analysis (Olson 2002), we chose to
retain the minmax mode of inheritance in our covariate
analyses to avoid additional multiple testing. Covariate
effects were considered signiﬁcant when the LOD score
for the covariate model was 0.83 LOD units larger than
the one-parameter baseline LOD, corresponding to the
level of signiﬁcance.ap 0.05
Covariates chosen were the number of females in the
ARP (sex) and the number of ﬁrst-degree affected rela-
tives, living and deceased, in the nuclear family containing
the ASP (Naff). Sex was chosen as a covariate, since pre-
vious studies found that females have an increased risk
of IA (Sekhar and Heros 1981; Østergaard 1989; Kissela
et al. 2002). The covariate distributions in the two sub-
populations were similar (tables 3 and 4). Inclusion of
sex as a covariate did not signiﬁcantly increase the LOD
score in either sample (except the Phase II sample at 60
cM), which suggested that the subtype of IA due to this
locus does not present a sex ratio that differs from that
of the overall sample. The covariate Naff, on the other
hand, signiﬁcantly increased the LOD scores (ﬁg. 1; ta-
ble 2). The highest LOD scores (and corresponding P
values for overall linkage) were seen at 70 cM in the
Phase I, Phase II, and combined sample sets: LOD score
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Figure 1 Multipoint LOD score analyses for chromosome 19. A, One-parameter baseline linkage analysis that allows for the inclusion
of covariates. Note that the mode of inheritance is not optimal, which resulted in a decrease of LOD scores compared with the two-parameter
baseline (table 2). B, One-parameter linkage analysis with Naff as a covariate. The covariate signiﬁcantly increased the LOD scores, which reached
maximum values at 70 cM (LOD score 5.70) and at 80 cM (LOD score 3.99). The horizontal bars below each plot indicate the GENEFINDER
(Department of Biostatistics Web site, Johns Hopkins University) 95% CIs (table 5) for the recessive (R), dominant (D), and partial-penetrance
(P) models, respectively.
Figure 2 Model-based multipoint LOD score for chromosome
19. The plot shows the results from a recessive model, with disease
allele frequency of 0.01, disease penetrance of 0.3, and a phenocopy
penetrance of 0.01. Note that the solid line (all families) and the dashed
line (families with more than two affected individuals) very nearly over-
lap; therefore, the dashed line is visible only in a few places.
2.55 ( ), LOD score 3.21 ( ), andPp .0017 Pp .0004
LOD score 5.70 ( ), respectively. These re-Pp .000001
sults suggest that families with larger numbers of af-
fected individuals are more likely to have linkage to this
region. We recognized, however, that signiﬁcance of this
covariate might simply reﬂect the possibility that pairs
from larger families often provide better information
about allele sharing and thus may provide more power
to detect linkage. We therefore tested a measure of
marker informativeness (Kruglyak and Lander 1995;
Kruglyak et al. 1996) as a covariate, but we observed
little, if any, increases in LOD scores from the baseline
model (results not shown), suggesting that evidence of
stronger linkage in pairs from larger families is not ex-
plained by marker informativeness.
The model-free linkage results suggested that ARPs
from families with more affected individuals are more
likely to show linkage and that the mode of inheritance
is most likely recessive. To verify this, we followed up
with multipoint model-based analysis (MLOD) (S.A.G.E.
2003), under the assumption of a recessive model with a
disease allele frequency of 0.01 and the penetrances of
the normal genotypes (i.e., phenocopy penetrance for spo-
radic cases) of 0.01. We then varied the penetrance of the
disease genotype from 0.1 to 0.8 in increments of 0.1.
This analysis included 15 additional multicase families
with types of ARPs that are not analyzed by LODPAL
(such as offspring of half-siblings or parent-offspring
pairs) but can be included in model-based analyses that
allow for arbitrary pedigree structures. The largest LOD
scores, obtained using a penetrance of 0.3, are shown in
ﬁgure 2 for the total sample of 136 families (LOD score
3.16; ), for 58 families with more than twoPp .00007
affected individuals (LOD score 3.15; ), andPp .00007
for 78 families with two affected individuals (LOD score
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Table 5
Predictions of the Candidate Gene Location for IA with 95% CI
Genetic Model
and Penetrances Z (P)
95% CI
(cM)
Midpoint Position
in cM
(Nearest Marker)
Recessive:
0, 0, and 1 3.43 (.00031) 68.1–80.4 74.2 (D19S606)
.2, .2, and .7 3.80 (.000073) 70.1–81.7 75.9 (D19S246)
Dominant:
0, 1, and 1 2.26 (.012) 60.1–76.1 68.1 (D19S718)
.2, .7, and .7 3.80 (.000073) 70.1–81.7 75.9 (D19S246)
NOTE.—Results were generated using the program GENEFINDER
(Department of Biostatistics Web site, Johns Hopkins University). Al-
lele frequency p 0.01.
0.10; ). Varying the disease allele frequency andPp .25
phenocopy penetrances did not improve the LOD scores.
In parallel with our model-free results, families withmore
than two affected individuals contributed disproportion-
ately to the linkage signal.
We tentatively interpret these results as supporting that
there may be two IA susceptibility loci in close proximity
on chromosome 19q, but location estimates of suscepti-
bility loci by nonparametric analyses for small samples of
complex diseases have been demonstrated to yield sub-
stantial variation (Roberts et al. 1999). We therefore ob-
tained 95% CIs for the location of the gene on chromo-
some 19 under different genetic models (table 5; ﬁg. 1).
For models with complete penetrance and no phenocop-
ies, the recessive model was a better ﬁt ( ;Zp 3.43 Pp
) than the dominant model ( ;.00031 Zp 2.26 Pp
). Here, Z is an asymptotically normally distributed.012
linkage statistic at the location of maximum estimated
sharing, as estimated by the programGENEFINDER (De-
partment of Biostatistics Web site, Johns Hopkins Uni-
versity). For models with incomplete penetrance and phe-
nocopies, recessive and dominant models gave identical
results ( ; ). Additional analysesZp 3.80 Pp .000073
that included the number of affected individuals as a
covariate and/or used lower penetrance values did not
further narrow the CI. The latter models deﬁned a can-
didate region with CIs of 11.6 cM, centered ∼2 cMprox-
imal to D19S246. This CI included linkage peaks at both
70 cM (D19S545) and 80 cM (D19S246) (ﬁg. 1). The
95% CIs obtained for both recessive models and the
dominant model with incomplete penetrance overlap at
markers D19S545, D19S606, and D19S246, with
D19S545–D19S606 being the most likely interval.
Our results suggest that the most likely location for a
susceptibility gene to IA is ﬂanked by markers D19S545
and D19S246, the region that includes marker D19S606.
There are currently 135 genes annotated in that region,
of which 33 are predicted genes with an unknown func-
tion. If we consider the physiological and biological in-
formation on the 102 characterized genes, some plausible
candidates include: (1) the D site of the albumin promoter
(albumin D-box)–binding protein (DBP [MIM 124097;
HUGO]), which is induced by angiotensin II in vascular
smooth-muscle cells (Nonaka et al. 2001); (2) the histi-
dine-rich calcium-binding protein (HRC [MIM 142705;
HUGO]), which plays a role in the sarcoplasmic reticulum
function and could thereby inﬂuence cerebral artery di-
ameter (Pathak et al. 1992; Wellman et al. 2002); (3) the
nitric oxide synthase–interacting protein (NOSIP [Locus-
Link locus ID 51070; HUGO]), a modulator of endothe-
lial nitric oxide synthase activity (Dedio et al. 2001); and
(4) the tumor upregulated CARD-containing antagonist
of caspase nine (CARD8 [LocusLink locus ID 22900;
HUGO]), involved in cell survival (Razmara et al. 2002).
In conclusion, our follow-up studies on chromosome
19q13 strongly support our hypothesis that this locus
harbors susceptibility genes for IA. Our results showed
that ARPs from families with larger numbers of affected
individuals provided the most linkage evidence, whereas
inclusion of sex as a covariate did not signiﬁcantly in-
crease the LOD score. On the basis of our linkage analy-
ses and further reﬁnement of the candidate region with
95% CIs, we conclude that the most likely location for
a gene predisposing to IA in our Finnish sample is a 6.6-
cM region on chromosome 19q13.3 between markers
D19S545 and D19S246. Future directions for research
include high-resolution ﬁne mapping of the 95% CI,
prioritization of potential candidate genes by gene-ex-
pression analyses in IA tissues, and association studies
of candidate genes in the interval. The locus described
here is, however, most probably not the only locus pre-
disposing families to IA. That fact was demonstrated by
a linkage study in the Japanese population (Onda et al.
2001), which found different loci from those in the Finns.
The major Japanese locus could, however, not be rep-
licated in a highly selected sample of Japanese families
with IA (Yamada et al. 2003), suggesting within-popu-
lation heterogeneity. Such heterogeneity is not surprising,
since (sub)population isolates can have different popu-
lation histories and thus harbor different disease suscep-
tibility loci. Replication studies in a variety of popu-
lations would give insight into the global representation
of the 19q13.3 IA locus conﬁrmed here.
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